Naloxone hydrochloride related impurity 2 and impurity 3 and preparation method thereof

By reacting with selenium dioxide under acidic conditions and using reversed-phase liquid chromatography for separation and purification, high-purity naloxone hydrochloride impurities 2 and 3 were prepared, solving the structural and source problems of unknown impurities in naloxone hydrochloride injection and improving drug quality and safety.

CN119039310AInactive Publication Date: 2024-11-29SHANDONG XINHUA PHARMA CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411528265.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-30
Publication Date
2024-11-29
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing technology contains unknown impurities in naloxone hydrochloride injection, whose structure and source are difficult to determine, affecting the quality and safety of the drug.

Method used

Using naloxone hydrochloride as the starting material, it reacts with selenium dioxide and water under acidic conditions, and is then separated and purified by reversed-phase liquid chromatography to obtain high-purity impurities 2 and 3. Trifluoroacetic acid is removed by preparative liquid chromatography to ensure the stability of the impurities.

Benefits of technology

The purity of impurities 2 and 3 obtained is over 90%, which can be used for quality research of naloxone hydrochloride formulations, providing a basis for formulation research, process improvement and storage conditions. The raw materials are readily available, the process parameters are controllable, and the reaction is mild.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119039310A_ABST
    Figure CN119039310A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of medical chemistry, and particularly relates to a naloxone hydrochloride related impurity 2 and impurity 3 and a preparation method thereof. The structural formulas of the naloxone hydrochloride related impurity 2 and impurity 3 disclosed by the invention are as follows: # imgabs 0 # and # imgabs 1 #. The preparation method of the naloxone hydrochloride related impurity 2 and impurity 3 comprises the following steps: dissolving naloxone hydrochloride in acid, adding selenium dioxide and water, heating for reaction, and cooling to room temperature to obtain a sample solution; separating and preparing by preparing a liquid phase, and collecting a target peak solution; evaporating the naloxone hydrochloride impurity 3 collection liquid under reduced pressure to remove the organic solvent, and freeze-drying to obtain an impurity 3; adding a naloxone hydrochloride impurity 2 collecting solution into an ammonium bicarbonate aqueous solution, preparing a liquid phase to remove trifluoroacetic acid, collecting a target peak solution, evaporating the collecting solution under reduced pressure to remove an organic solvent, and freeze-drying to obtain the impurity 2.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to naloxone hydrochloride related impurities 2 and 3 and a preparation method thereof, belonging to the technical field of pharmaceutical chemistry. Background Art

[0002] Naloxone hydrochloride is a pure opioid receptor antagonist. It has no intrinsic activity itself, but it can competitively antagonize various opioid receptors and has a strong affinity for μ receptors. Naloxone takes effect quickly and has a strong antagonistic effect. Naloxone can simultaneously reverse all effects of opioid agonists, including analgesia. Naloxone can quickly reverse the respiratory depression caused by opioids, can cause high excitement, and cause cardiovascular hyperfunction. Naloxone has an anti-shock effect. In addition, naloxone also has a recovery effect that is not related to antagonizing opioid receptors. Unlike morphine, naloxone does not produce dependence, withdrawal symptoms, and respiratory depression.

[0003] Naloxone hydrochloride is the most widely used opioid receptor antagonist in clinical practice. Its clinical indications include acute poisoning by narcotic analgesics and acute alcohol poisoning. It is first used for respiratory depression and coma caused by known or suspected opioid overdose, and can also be used for the differential diagnosis of opioid addicts.

[0004] At present, some unknown impurities have appeared in the stability study of naloxone hydrochloride injection. In order to ensure the safety of medication and fully study the quality and properties of naloxone hydrochloride injection, it is necessary to clarify the structure of these unknown impurities, attribute the source and category of the impurities, and provide a basis for determining the appropriate preparation process and storage conditions in the preparation research. Therefore, the preparation method of these impurities was studied, and the target impurities were prepared in a researchable amount, and the structure was confirmed. Summary of the invention

[0005] The purpose of the present invention is to provide two related impurities 2 and impurity 3 of naloxone hydrochloride and a preparation method thereof. The prepared impurities 2 and impurity 3 have high purity and are of positive significance for the formulation research, process research, and storage condition research of naloxone hydrochloride preparations. The raw materials used in the present invention are easily available, the process parameters are controllable, and the reaction is mild.

[0006] The structural formulas of the impurities 2 and 3 are as follows: , .

[0007] The method for preparing naloxone hydrochloride related impurities 2 and 3 of the present invention comprises the following steps: (1) Dissolve naloxone hydrochloride in acid, add selenium dioxide and water, and heat to react. After the reaction is complete, cool to room temperature to obtain a sample solution.

[0008] (2) Separate and prepare the sample solution through preparative liquid phase and collect the target peak solution.

[0009] (3) The impurity 3 collected solution was evaporated under reduced pressure to remove the organic solvent, and then freeze-dried to obtain the target impurity 3.

[0010] (4) The impurity 2 collection solution is added to an aqueous solution of ammonium bicarbonate, and then the trifluoroacetic acid is removed by preparative liquid phase, and the target peak solution is collected. The collected solution is evaporated under reduced pressure to remove the organic solvent, and then freeze-dried to obtain the target impurity 2.

[0011] Wherein, in the step (1), the acid used is formic acid or acetic acid; and the ratio of naloxone hydrochloride to acid, selenium dioxide and water is 1:20:0.05-0.15:10 (g / mL / g / mL).

[0012] In the step (1), the reaction temperature is 45-55°C and the reaction time is 24-36h.

[0013] In the step (2), the conditions for preparing the liquid phase separation are: Chromatographic column: Xtimate C18 50×250mmol / L 10μm; Detection wavelength: 230nm; The mobile phase and gradient are shown in Table 1, where % and ‰ refer to the volume ratio.

[0014] Table 1 Mobile phase and gradient

[0015] Flow rate: 100 mL / min; Injection volume: 9.5~10.5mL; In the step (3), the temperature for distilling off the organic solvent (acetonitrile) under reduced pressure is 25-35°C.

[0016] In the step (4), the aqueous solution of ammonium bicarbonate used is 10 mmol / Lol / L aqueous solution of ammonium bicarbonate, and the ratio of the impurity 2 collection solution to the aqueous solution of ammonium bicarbonate is 2:3 (V / V).

[0017] In the step (4), the conditions for preparing the liquid phase to remove trifluoroacetic acid are: Chromatographic column: Xtimate C18 50×250mmol / L 10μm; Detection wavelength: 230nm; Flow rate: 100 mL / min; Process: First, pump the impurity 2 collection solution and the mixed solution of ammonium bicarbonate aqueous solution (2:3) (V / V) into the chromatographic column; then use the mixed solution of ammonium bicarbonate aqueous solution and acetonitrile (96:4) (V / V) to elute the trifluoroacetic acid for 8 minutes; then use the mixed solution of ammonium bicarbonate aqueous solution and acetonitrile (90:10) (V / V) to elute the impurity 2 and collect the target peak solution.

[0018] In the step (4), the temperature for distilling off the organic solvent (acetonitrile) under reduced pressure is 25-35°C.

[0019] The reaction principle of the present invention is as follows: .

[0020] The present invention uses naloxone hydrochloride as a starting material, destroys it under acidic conditions to produce impurities 2 and impurity 3, and obtains target impurities 2 and impurity 3 through reverse liquid phase preparative separation and purification; in order to ensure the stability of impurity 2, trifluoroacetic acid needs to be removed by using a preparative liquid phase.

[0021] Compared with the prior art, the present invention has the following beneficial effects: The target impurities 2 and 3 prepared by the present invention have a purity of more than 90%, and can be used as impurity reference substances for quality research of naloxone hydrochloride. The present invention has positive significance for the formulation research, process improvement, and storage condition research of naloxone hydrochloride preparations. The raw materials used in the present invention are easily available, the process parameters are controllable, and the reaction is mild. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1 HPLC spectrum of impurity 2 in Example 1; Figure 2 Mass spectrum of impurity 2 in Example 1; Figure 3 Hydrogen spectrum of impurity 2 in Example 1; Figure 4 Carbon spectrum of impurity 2 in Example 1; Figure 5 COSY spectrum of impurity 2 in Example 1; Figure 6 HMBC spectrum of impurity 2 in Example 1; Figure 7 HSQC spectrum of impurity 2 in Example 1; Figure 8 HPLC spectrum of impurity 3 in Example 1; Fig. 9 Mass spectrum of impurity 3 in Example 1; Fig.10 Hydrogen spectrum of impurity 3 in Example 1; Fig.11 Carbon spectrum of impurity 3 in Example 1; Fig.12 COSY spectrum of impurity 3 in Example 1; Fig.13 HMBC spectrum of impurity 3 in Example 1; Fig.14 HSQC spectrum of impurity 3 in Example 1. DETAILED DESCRIPTION

[0023] The specific implementation modes of the present invention are further described below in conjunction with embodiments.

[0024] Example 1 The method for preparing the naloxone hydrochloride related impurities 2 and 3 comprises the following steps: Weigh 1.0g of naloxone hydrochloride API into a reaction bottle, add 20mL of formic acid, stir to dissolve, add 0.10g of selenium dioxide and 10mL of water, heat to 50℃, and keep warm for 30h. Cool to room temperature to obtain a sample solution, HPLC: impurity 2: 5.23%; impurity 3: 8.53%.

[0025] The sample solution was separated and prepared by preparative liquid phase separation. The conditions for preparative liquid phase separation were as follows: Chromatographic column: Xtimate C18 50×250mmol / L 10μm; Detection wavelength: 230nm; The mobile phase and gradient are shown in Table 1; Flow rate: 100 mL / min; Injection volume: 10±0.5mL; The peak solutions of impurity 2 and impurity 3 were collected separately.

[0026] The impurity 3 collected was evaporated under reduced pressure at 30°C to remove acetonitrile, and then freeze-dried to obtain the target impurity 3, with an HPLC content of 93.53%; ESI-MS: m / z=360.14383 ([M+H] + ); 1 H-NMR (D2O, 600MHz): δ ppm : 1.93 (1H, dd), 2.59 (1H, d), 2.68 (1H, td), 2.89 (1H, d), 2.95 (1H, td), 3.17 (1H, dd), 3.30 (1H, dd), 3.45 (1H, d), 3.87 (2H, d), 3.91 (1H, d), 4.81 (1H, s), 5.62(2H, q), 5.89 (1H, q), 6.79(1H, d), 6.85 (1H, d); 13C-NMR (D2O, 150MHz): δ ppm : 22.50, 28.87, 44.72, 45.50, 47.01, 55.92, 61.01, 71.72, 92.11, 93.19, 119.32, 121.10, 122.73, 125.55, 126.56, 126.64, 138.20, 143.92, 203.75.

[0027] The HPLC spectrum of Naloxone Hydrochloride Impurity 3 is as follows: Figure 8 , mass spectrum as Fig. 9 , the hydrogen spectrum is as follows Fig.10 , carbon spectrum as Fig.11 , COSY spectrum is as follows Fig.12 , HMBC spectrum is as follows Fig.13 , HSQC spectrum is as follows Fig.14 .

[0028] Figure 8 The results of the chromatographic peaks in are shown in Table 2.

[0029] Table 2 Chromatographic peak results

[0030] The impurity 2 collection solution was mixed with 10mmol / L ammonium bicarbonate aqueous solution at 2:3 (V / V), and then trifluoroacetic acid was removed by preparative liquid phase. The conditions for preparative liquid phase removal of trifluoroacetic acid are: Chromatographic column: Xtimate C18 50×250mmol / L 10μm; Detection wavelength: 230nm; Flow rate: 100 mL / min; Process: First, pump the impurity 2 collection solution and a mixed solution of ammonium bicarbonate aqueous solution (2:3) (V / V) into the chromatographic column; then use a mixed solution of ammonium bicarbonate aqueous solution and acetonitrile (96:4) (V / V) to elute trifluoroacetic acid for 8 minutes; then use a mixed solution of ammonium bicarbonate aqueous solution and acetonitrile (90:10) (V / V) to elute impurity 2 and collect the target peak solution.

[0031] The impurity 2 collected solution was evaporated at 30°C under reduced pressure to remove acetonitrile, and then freeze-dried to obtain the target impurity 2, with an HPLC content of 91.89%; ESI-MS: m / z=342.13342 ([M+H] + ); 1 H-NMR (D2O, 600MHz): δ ppm:1.92 (1H, d), 2.20(1H, dt), 2.83 (2H, d), 2.97 (1H, dd), 3.35 (2H, d), 3.37 (1H, d), 4.10(1H, d), 4.90 (1H, s), 5.33 (2H, m), 5.85 (1H, m), 6.14 (1H, s), 6.72 (1H, d), 6.81 (1H, d); 13 C-NMR (D2O, 150MHz): δ ppm The data are as follows: 29.23, 35.34, 42.81, 45.79, 55.79, 58.37, 91.91, 91.98, 117.78, 118.31, 120.47, 120.81, 125.59, 129.30, 132.22, 137.63, 144.22, 196.07.

[0032] The HPLC spectrum of Naloxone Hydrochloride Impurity 2 is as follows: Figure 1 , mass spectrum as Figure 2 , the hydrogen spectrum is as follows Figure 3 , carbon spectrum as Figure 4 , COSY spectrum is as follows Figure 5 , HMBC spectrum is as follows Figure 6 , HSQC spectrum is as follows Figure 7 .

[0033] Figure 1 The results of the chromatographic peaks in are shown in Table 3.

[0034] Table 3 Chromatographic peak results

[0035] Example 2 The method for preparing the naloxone hydrochloride related impurities 2 and 3 comprises the following steps: Weigh 1.0 g of naloxone hydrochloride API into a reaction bottle, add 20 mL of acetic acid, stir to dissolve, add 0.15 g of selenium dioxide and 10 mL of water, heat to 55°C, keep warm for 24 hours, and cool to room temperature to obtain a sample solution.

[0036] The sample solution was separated and prepared by using preparative liquid phase separation, and the conditions for the preparative liquid phase separation were the same as those in Example 1.

[0037] The peak solutions of impurity 2 and impurity 3 were collected separately.

[0038] The impurity 3 collected solution was evaporated under reduced pressure at 35°C to remove acetonitrile, and then freeze-dried to obtain the target impurity 3 with an HPLC content of 92.83%.

[0039] The impurity 2 collection solution was mixed with 10 mmol / L ammonium bicarbonate aqueous solution at a ratio of 2:3 (V / V), and then trifluoroacetic acid was removed by preparative liquid phase. The conditions and process of preparative liquid phase trifluoroacetic acid removal were the same as those in Example 1. The collection solution was evaporated under reduced pressure at 35°C to remove acetonitrile, and then freeze-dried to obtain the target impurity 2, with an HPLC content of 91.54%.

[0040] Example 3 The method for preparing the naloxone hydrochloride related impurities 2 and 3 comprises the following steps: Weigh 1.0g of naloxone hydrochloride API into a reaction bottle, add 20mL of formic acid, stir to dissolve, add 0.05g of selenium dioxide and 10mL of water, heat to 55°C, keep warm for 30h, cool to room temperature, and obtain a sample solution.

[0041] The sample solution was separated and prepared by using preparative liquid phase separation, and the conditions for the preparative liquid phase separation were the same as those in Example 1.

[0042] The peak solutions of impurity 2 and impurity 3 were collected separately.

[0043] The impurity 3 collected solution was evaporated under reduced pressure at 30°C to remove acetonitrile, and then freeze-dried to obtain the target impurity 3 with an HPLC content of 94.98%.

[0044] The impurity 2 collection solution was mixed with 10 mmol / L ammonium bicarbonate aqueous solution at a ratio of 2:3 (V / V), and then trifluoroacetic acid was removed by preparative liquid phase. The conditions and process of preparative liquid phase trifluoroacetic acid removal were the same as those in Example 1. The collection solution was evaporated under reduced pressure at 30°C to remove acetonitrile, and then freeze-dried to obtain the target impurity 2, with an HPLC content of 92.17%.

[0045] Example 4 The method for preparing the naloxone hydrochloride related impurities 2 and 3 comprises the following steps: Weigh 1.0 g of naloxone hydrochloride API into a reaction bottle, add 20 mL of formic acid, stir to dissolve, add 0.15 g of selenium dioxide and 10 mL of water, heat to 45°C, keep warm for 36 hours, cool to room temperature, and obtain a sample solution.

[0046] The sample solution was separated and prepared by using preparative liquid phase separation, and the conditions for the preparative liquid phase separation were the same as those in Example 1.

[0047] The peak solutions of impurity 2 and impurity 3 were collected separately.

[0048] The impurity 3 collected solution was evaporated under reduced pressure at 25°C to remove acetonitrile, and then freeze-dried to obtain the target impurity 3 with an HPLC content of 94.21%.

[0049] The impurity 2 collection solution was mixed with 10 mmol / L ammonium bicarbonate aqueous solution at 2:3 (V / V), and then trifluoroacetic acid was removed by preparative liquid phase. The conditions and process of preparative liquid phase trifluoroacetic acid removal were the same as those in Example 1. The collection solution was evaporated under reduced pressure at 30°C to remove acetonitrile, and then freeze-dried to obtain the target impurity 2, with an HPLC content of 92.08%.

[0050] Example 5 The method for preparing the naloxone hydrochloride related impurities 2 and 3 comprises the following steps: Weigh 1.0 g of naloxone hydrochloride API into a reaction bottle, add 20 mL of acetic acid, stir to dissolve, add 0.10 g of selenium dioxide and 10 mL of water, heat to 50°C, keep warm for 30 hours, and cool to room temperature to obtain a sample solution.

[0051] The sample solution was separated and prepared by using preparative liquid phase separation, and the conditions for the preparative liquid phase separation were the same as those in Example 1.

[0052] The peak solutions of impurity 2 and impurity 3 were collected separately.

[0053] The impurity 3 collected solution was evaporated under reduced pressure at 30°C to remove acetonitrile, and then freeze-dried to obtain the target impurity 3 with an HPLC content of 93.11%.

[0054] The impurity 2 collection solution was mixed with 10 mmol / L ammonium bicarbonate aqueous solution at a ratio of 2:3 (V / V), and then trifluoroacetic acid was removed by preparative liquid phase. The conditions and process of preparative liquid phase trifluoroacetic acid removal were the same as those in Example 1. The collection solution was evaporated under reduced pressure at 30°C to remove acetonitrile, and then freeze-dried to obtain the target impurity 2, with an HPLC content of 92.26%.

[0055] The present invention is described in detail above in conjunction with the embodiments, but the contents described are only preferred embodiments of the present invention and cannot be considered to limit the scope of implementation of the present invention. All equivalent changes and improvements made within the scope of the present invention should still fall within the scope of the patent coverage of the present invention.

Claims

1. A naloxone hydrochloride related impurity 2 and impurity 3, characterized in that: The structural formula is as follows: 、 。 2. A method for preparing the naloxone hydrochloride related impurities 2 and 3 according to claim 1, characterized in that: The following steps are involved: (1) Dissolve naloxone hydrochloride in acid, add selenium dioxide and water, heat to react, and after the reaction is complete, cool to room temperature to obtain a sample solution; (2) Separating and preparing the sample solution through preparative liquid phase and collecting the target peak solution; (3) The impurity 3 collected solution was evaporated under reduced pressure to remove the organic solvent, and then freeze-dried to obtain the target impurity 3; (4) The impurity 2 collection solution is added to an aqueous solution of ammonium bicarbonate, and then the trifluoroacetic acid is removed by preparing a liquid phase, and the target peak solution is collected. The collected solution is evaporated under reduced pressure to remove the organic solvent, and then freeze-dried to obtain the target impurity 2.

3. The method for preparing naloxone hydrochloride related impurities 2 and 3 according to claim 2, characterized in that: In step (1), the acid used is formic acid or acetic acid; the ratio of naloxone hydrochloride to acid, selenium dioxide and water is 1:20:0.05-0.15:10 (g / mL / g / mL).

4. The method for preparing naloxone hydrochloride related impurities 2 and 3 according to claim 2, characterized in that: In step (1), the reaction temperature is 45-55°C and the reaction time is 24-36h.

5. The method for preparing naloxone hydrochloride related impurities 2 and 3 according to claim 2, characterized in that: In step (2), the conditions for preparing the liquid phase separation are: Chromatographic column: Xtimate C18 50×250mmol / L 10μm; Detection wavelength: 230nm; Mobile phase and gradient: 0min, 98% trifluoroacetic acid aqueous solution-2% acetonitrile; 10min, 90% trifluoroacetic acid aqueous solution-10% acetonitrile; 16min, 90% trifluoroacetic acid aqueous solution-10% acetonitrile; 17min, 40% trifluoroacetic acid aqueous solution-60% acetonitrile; 22min, 40% trifluoroacetic acid aqueous solution-60% acetonitrile; 22.1min, 98% trifluoroacetic acid aqueous solution-2% acetonitrile; 25min, 98% trifluoroacetic acid aqueous solution-2% acetonitrile; the concentration of the trifluoroacetic acid aqueous solution is 1‰; Flow rate: 100 mL / min; Injection volume: 9.5~10.5mL.

6. The method for preparing naloxone hydrochloride related impurities 2 and 3 according to claim 2, characterized in that: In step (3), the temperature for distilling off the organic solvent under reduced pressure is 25 to 35°C.

7. The method for preparing naloxone hydrochloride related impurities 2 and 3 according to claim 2, characterized in that: In step (4), the aqueous solution of ammonium bicarbonate used is 10 mmol / Lol / L aqueous solution of ammonium bicarbonate, and the volume ratio of the impurity 2 collection solution to the aqueous solution of ammonium bicarbonate is 2:

3.

8. The method for preparing naloxone hydrochloride related impurities 2 and 3 according to claim 2, characterized in that: In step (4), the conditions for removing trifluoroacetic acid from the prepared liquid phase are: Chromatographic column: Xtimate C18 50×250mmol / L 10μm; Detection wavelength: 230nm; Flow rate: 100 mL / min; Process: First, the impurity 2 collection solution and the ammonium bicarbonate aqueous solution were mixed in a volume ratio of 2:3 and pumped into the chromatographic column; then, the trifluoroacetic acid was eluted for 8 minutes with a mixed solution of ammonium bicarbonate aqueous solution and acetonitrile in a volume ratio of 96:4; then, the impurity 2 was eluted with a mixed solution of ammonium bicarbonate aqueous solution and acetonitrile in a volume ratio of 90:10, and the target peak solution was collected.

9. The method for preparing naloxone hydrochloride related impurities 2 and 3 according to claim 2, characterized in that: In step (4), the temperature for distilling off the organic solvent under reduced pressure is 25 to 35°C.

Citation Information

Patent Citations

  • Synthetic method of naloxone hydrochloride

    CN104230945A

  • Method for determining naloxone hydrochloride impurity D by using liquid chromatography

    CN116482286A